regeneron 23andme - Search News

Order byBest matchMost fresh

News

Regeneron buying 23andMe

Does the 23andMe Acquisition Make Regeneron a Buy Now?

Recently, Regeneron ( REGN -1.41%) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its previous market value. You might remember that the genetic testing company filed for Chapter 11 bankruptcy protections in March.

Continue reading

Regeneron buying 23andMe; What happened to 23andMe? Should I delete 23andMe data?

Medindia · 33m

Regeneron Acquires 23andMe in $256M Deal

Predictive Oncology breakthrough coincides with Regeneron Pharma’s acquisition of 23andMe for $256 million: Artificial intelligence meets genomics

Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

2d

Regeneron's 23andMe Steal - Smart Genetics Play That Won't Cure Near-Term Growth Pains

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

The Hudson Independent1d

Regeneron Enters into Agreement to Acquire Consumer Genetics Business

Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...

23andMe and its user data will soon belong to a pharmaceutical giant

23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results